Scientists show that SR-3306 delivered orally to mice and rat models of Parkinson's disease was able to protect brain cells from neurodegeneration. SR-3306 inhibits the c-jun-N-terminal kinases (JNK) class of enzymes, previously shown to play large roles in neuron survival.